2020
DOI: 10.3389/fpsyg.2020.01979
|View full text |Cite
|
Sign up to set email alerts
|

Responding to the Spiritual Needs of Palliative Care Patients: A Randomized Controlled Trial to Test the Effectiveness of the Kibo Therapeutic Interview

Abstract: Context: The WHO recognizes the need to attend to patients' spiritual needs as being fundamental to comprehensive and high-quality end-of-life care. Spiritual needs must be attended to since the resolution of biological and psychosocial issues is insufficient to reduce patients' suffering. Associations have been found between spiritual needs and other variables of importance for patients in palliative care. Despite the consensus that exists regarding the importance of assessing and attending to spiritual needs… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 56 publications
0
11
0
Order By: Relevance
“…The 14 included studies were conducted in the United States (Agin-Liebes et al, 2020; Nelson et al, 2019; Ross et al, 2016, 2021), Germany (Fraguell-Hernando et al, 2020; Mehnert et al, 2020), China (Li et al, 2020; Sun et al, 2021), Spain (Soto-Rubio et al, 2020), Ireland (Sarizadeh et al, 2021), Italy (Iani et al, 2020), Portugal (Juliao et al, 2017), Australia (Kissane et al, 2019), and Canada (Rodin et al, 2018). Nine studies were RCTs (Agin-Liebes et al, 2020; Iani et al, 2020; Juliao et al, 2017; Mehnert et al, 2020; Rodin et al, 2018; Ross et al, 2016, 2021; Sarizadeh et al, 2021; Soto-Rubio et al, 2020), four studies were pilot studies (Fraguell-Hernando et al, 2020; Kissane et al, 2019; Nelson et al, 2019; Sun et al, 2021), and one study was quasi-experimental study (Li et al, 2020). The sample size of each study ranged from 11 to 305 participants, with a total sample size of 1049 patients with cancer.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…The 14 included studies were conducted in the United States (Agin-Liebes et al, 2020; Nelson et al, 2019; Ross et al, 2016, 2021), Germany (Fraguell-Hernando et al, 2020; Mehnert et al, 2020), China (Li et al, 2020; Sun et al, 2021), Spain (Soto-Rubio et al, 2020), Ireland (Sarizadeh et al, 2021), Italy (Iani et al, 2020), Portugal (Juliao et al, 2017), Australia (Kissane et al, 2019), and Canada (Rodin et al, 2018). Nine studies were RCTs (Agin-Liebes et al, 2020; Iani et al, 2020; Juliao et al, 2017; Mehnert et al, 2020; Rodin et al, 2018; Ross et al, 2016, 2021; Sarizadeh et al, 2021; Soto-Rubio et al, 2020), four studies were pilot studies (Fraguell-Hernando et al, 2020; Kissane et al, 2019; Nelson et al, 2019; Sun et al, 2021), and one study was quasi-experimental study (Li et al, 2020). The sample size of each study ranged from 11 to 305 participants, with a total sample size of 1049 patients with cancer.…”
Section: Resultsmentioning
confidence: 99%
“…Based on the content of the interventions, we briefly classified the included interventions into five types, namely, psilocybin-assisted psychotherapy, meaning-related psychotherapy, CALM therapy, DT, and other interventions (Cancer and Aging: Reflections for Elders [CARE]—psychotherapy, Acceptance and Commitment Therapy [ACT], and Kibo Therapeutic Interview). Six studies indicated that one of the aims of the study was to improve demoralization among patients with cancer (Iani et al, 2020; Juliao et al, 2017; Li et al, 2020; Sarizadeh et al, 2021; Soto-Rubio et al, 2020; Sun et al, 2021). In addition, demoralization was a secondary outcome indicator in other studies.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations